PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial) (PAF-HEFT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00839566
(Number of eligible patients too small.)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
QRS time ≥150ms LBB
NYHA classification ≥ NYHA III
permanent (> 6 months) Atrial Fibrillation
sinus rhythm (control group)
Condition after Implantation of a Medtronic CRT device
written informed consent
exchange of the current CRT device
mitral incompetence (2. degree)
participation in another study
patients with AV node
patients after heart transplant or those who are on the transplant list